The Medicines and Healthcare Products Regulatory Agency has today announced the reclassification of an antimalarial tablet from prescription-only to a P medicine.
Sold under the brand name Maloff Protect the tablets contain two antimalarial agents, atovaquone and proguanil. They will be available to adults over 18, weighing more than 40kg, travelling to areas affected by malaria and where the malaria parasite is not resistant to the Maloff Protect ingredients.
Mr Martin Astbury, President of the Royal Pharmaceutical Society
“This is good news for both pharmacists and travellers. It means people travelling abroad can access the medicine at their convenience and without a prescription from their GP, which would undoubtedly result in better access to protection from malaria.
"Pharmacists already offer a full range of travel advice, and in some cases vaccinations too. Malaria prevention is a well-established area of expertise for pharmacists and a great opportunity to provide full travel advice to people travelling anywhere in the world.
"Pharmacists have access to up to date information and resources and are very well equipped to provide this medicine safely and appropriately. As the professional body for pharmacists, the RPS will be publishing professional guidance on this topic.”